In a study that upends current concepts of immunotherapies for breast cancer, researchers at Duke Cancer Institute have described a newly identified process for how the drug pertuzumab works in tandem with trastuzumab.  

Researchers at the Duke Human Vaccine Institute have demonstrated a successful way to deliver a potential HIV vaccine using mRNA technology, like that in the COVID-19 vaccines.

The difference between a social butterfly and a lone wolf is actually at least eight differences, according to new findings by a team of Duke brain researchers.

When Russia invaded Ukraine, mental health practitioners knew they needed to help families address the conflict with their children.

According to a study by the ABC Science Collaborative, school districts that required masking saw lower rates of COVID-19 transmission within schools last fall compared to those with optional masking policies.

Not only do these students work on their PhD theses to explore new scientific frontiers, they also move novel technologies from the bench out to the world through the OTC Fellows Program at Duke’s Office for Translation & Commercialization.

Two Duke pulmonologists speak with the media about symptoms, treatments and what remains unknown about long COVID.

A baby believed to be the first person to receive a combination heart transplant and allogeneic processed thymus tissue implantation appears to be gaining the immune cells necessary to reduce or eliminate the need for prolonged use of toxic anti-rejection drugs.

Susanna Naggie, MD, and Sudarshan Rajagopal, MD, PhD, have been elected to the American Society for Clinical Investigation (ASCI) for 2022.

The IOMP established the Marie Sklodowska-Curie Award to honor scientists who have distinguished themselves by their contributions to medical physics.